2/2/2025Vigonvita Life Sciences Submits IPO Application to Hong Kong Stock Exc...

2/2/2025ImmunityBio and BeiGene Partner on Phase 3 Trial of ANKTIVA and PD-1 I...

2/2/2025I-Mab Cuts 27% of Workforce Amid Strategic Shift

1/28/2025China's Evolving Role in Pharma Spurs Regional Realignments, Boosts In...

1/28/2025InnoCare's Efsubaglutide Alfa Receives Approval in China for Type 2 Di...

1/28/2025CStone Partners with SteinCares to Market Sugemalimab in Latin America

1/27/2025AsiFlyer Secures Series Pre-A++ Funding to Advance Botulinum Toxin Dru...

1/27/2025GeneQuantum Announces Strategic Collaborations with Biohaven and Aimed...

1/27/2025Lumiere Secures Series Pre-A Funding to Advance Gene Editing Research

1/24/2025Ab&B Biotech Submits IPO Application to Hong Kong Stock Exchange

1/24/2025Hengrui's Insulin Degludec BLA Accepted by China's NMPA

1/23/2025TargetRx Secures $50 Million in Series C Financing to Propel Global Cl...

1/23/2025Belief BioMed Announces IND Clearance by FDA for DMD Gene Therapy Cand...

1/22/2025Degron Secures $20M in Series A+ Financing to Advance Molecular Glue T...

1/22/2025Imbioray Secures Series A+ Financing to Advance NK Cell Therapy Pipeli...

1/22/2025Fosun Pharma’s Bid to Privatize Henlius Fails After Shareholder Rejec...

1/22/2025Shanghai Bao Pharma Files for IPO on HKSE

1/22/2025Qyuns Thera Secures CSRC Approval for Full H-share Circulation

1/21/2025China's Biopharma R&D Expands Global Influence in 2024

1/21/2025ArriVent Enters Exclusive License with Lepu Biopharma for MRG007, an A...

1/21/2025Sichuan Biokin Refiles for Hong Kong IPO Following Lapsed Application

1/21/2025 China-based Ascentage Pharma Targets $149M in US IPO

1/21/2025Fermion and Simcere Join Forces to Develop Non-Opioid Analgesic 

1/21/2025IVIEW Thera Completes Series A++ Financing to Advance Ophthalmology Pi...

1/20/2025JOINN Biologics Acquires Lonza's Large Molecule CDMO Facility in Guang...

1/20/2025InnoCare and KeyMed Jointly Enter License Deal with Prolium for CD20xC...

1/20/2025Junshi and LEO Enter Commercialization Partnership for Toripalimab in ...

1/20/2025InflamaX Secures Pre-A Investment for Immuno-Inflammatory Research  

1/17/2025Simnova and Orna Expand Partnership to Include BCMA-Targeted RNA Thera...

1/17/2025Bivision Secures ~CNY 100M in Series A+ Financing, Accelerates Targete...

Page:5/21 Total number of articles:607: [First][<<] [3] [4] [5] [6] [7] [>>] [End]